Non-motor outcomes and divergent plasma metabolite changes during continuous subcutaneous foslevodopa/foscarbidopa infusion in Parkinson's disease

Clinical Parkinsonism & Related Disorders · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles